Sirio Pharma Co Ltd
SZSE:300791
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (13.9), the stock would be worth ¥26.73 (38% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 10.1 | ¥19.4 |
0%
|
| 3-Year Average | 13.9 | ¥26.73 |
+38%
|
| 5-Year Average | 15.1 | ¥29.02 |
+50%
|
| Industry Average | 16.6 | ¥31.87 |
+64%
|
| Country Average | 20.8 | ¥39.92 |
+106%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Sirio Pharma Co Ltd
SZSE:300791
|
6B CNY | 10.1 | 17.3 | |
| FR |
|
L'Oreal SA
PAR:OR
|
199.5B EUR | 23 | 32.6 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
92.8B GBP | 12.2 | 11.3 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR | 46.1 | 37.1 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.2B GBP | 14.3 | 18.7 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28B USD | 19.2 | -156.7 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.8B EUR | 17 | 16.8 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 12.7 | 22.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 47.7 | 61.7 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 552.9 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
801.7B INR | 40.3 | 43.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.5 |
| Median | 20.8 |
| 70th Percentile | 39.2 |
| Max | 266 666.7 |
Other Multiples
Sirio Pharma Co Ltd
Glance View
Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.
